UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023.
Related Articles

News
Take 10 With a Triton: Alumnus Jose Perez Shares Why His Heart Belongs to Triton Transit
June 30, 2022
sandiegobiotech
News, UCSD News
Comments Off on Take 10 With a Triton: Alumnus Jose Perez Shares Why His Heart Belongs to Triton Transit
Jose Perez started his career in mass transit at UC San Diego nearly two decades ago, working as a shuttle driver for Triton Transit while pursuing an undergraduate degree in Urban Studies and Planning.
[…]

News
Adoption of E-cigarettes for Smoking Cessation in 2017 Low and Ineffective
February 7, 2022
sandiegobiotech
News, UCSD News
Comments Off on Adoption of E-cigarettes for Smoking Cessation in 2017 Low and Ineffective
Smokers were not early adopters of high nicotine e-cigarettes as cessation aids despite the rapid growth of sales of these products in 2017, report Herbert Wertheim School of Public Health and Human Longevity Science at Univers… […]

News
UC San Diego Breaks Record with $1.54B in Research Funding
August 18, 2021
sandiegobiotech
News, UCSD News
Comments Off on UC San Diego Breaks Record with $1.54B in Research Funding
In fiscal year 2021 (July 1-June 30), UC San Diego earned $1.54 billion in sponsored research funding, a 6% increase over the previous year. This is the largest number ever for the university and marks the 12th … […]